Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
SKRR to Commence Uranium Drill Program to Test Conductors at Clearwater West (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News NeuroMetrix Inc NURO

Healthcare Medical Devices
NeuroMetrix, Inc. is a commercial-stage healthcare company that develops and commercializes neurotechnology devices to address unmet needs in the chronic pain and diabetes markets. The Company's products are wearable or hand-held medical devices enabled by proprietary consumables and software solutions that include mobile apps, enterprise software and cloud-based systems. The Company has two... see more

Recent & Breaking News (NDAQ:NURO)

NeuroMetrix to Showcase Quell® Wearable Pain Relief at CES Unveiled

Business Wire November 9, 2015

NeuroMetrix Announces Distribution Agreement With Prism Health Care Services

Business Wire October 27, 2015

NeuroMetrix Reports Q3 2015 Financial Results and Highlights

Business Wire October 22, 2015

NeuroMetrix, Inc. Announces Date for 2015 Third Quarter Financial Results Conference Call

Business Wire October 14, 2015

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Breaches of Fiduciary Duty by the Board of NeuroMetrix Inc.

Business Wire October 8, 2015

Quell® Wearable Relief Technology Selected as Finalist in the Partners Healthcare's Connected Health Symposium Innovators Challenge

Business Wire October 8, 2015

NeuroMetrix Announces Launch of Quell Wearable Relief Technology in Hammacher Schlemmer Catalog

Business Wire October 6, 2015

NeuroMetrix Expands Investor Outreach with CorProminence LLC

Business Wire October 1, 2015

NeuroMetrix Launches Android App for Quell® Wearable Pain Relief Technology

Business Wire September 29, 2015

NeuroMetrix Gains National TV Exposure for Quell(TM) Wearable Technology on ABC's Good Morning America

Business Wire September 22, 2015

NeuroMetrix Reports Executive Stock Transactions during August 2015

Business Wire September 17, 2015

NeuroMetrix Showcases Quell(TM) Wearable Pain Relief Technology at the Pri-Med East Annual Conference

Business Wire September 15, 2015

NeuroMetrix Expands Sales of Quell(TM) Wearable Pain Relief Device on Amazon

Business Wire September 9, 2015

NeuroMetrix Showcases Quell(TM) Wearable Pain Relief Technology at the PAINWeek National Conference

Business Wire September 8, 2015

NeuroMetrix to Present at Rodman & Renshaw 17th Annual Global Investment Conference

Business Wire September 3, 2015

Quell(TM) Wearable Pain Relief Device Featured on QVC Television

Business Wire September 3, 2015

NeuroMetrix Reports Positive Pilot Data for Use of its Wearable Pain Relief Technology in Restless Leg Syndrome

Business Wire August 31, 2015

NeuroMetrix Reports Milestone for DPNCheck® Testing within the Medicare Advantage Market

Business Wire August 27, 2015

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Breaches of Fiduciary Duty by the Board of NeuroMetrix Inc.

PR Newswire August 26, 2015

NeuroMetrix Reports Positive Clinical Study Results for Quell(TM) Wearable Pain Relief Device

Business Wire August 18, 2015